In the present NSCLC patients, a high percentage of NK cells with cytotoxic-phenotype (CD56+CD16+) were observed in peripheral blood, and these cells were also frequently located in DNTT. This evidence concerns the gene NCAM1 and non-small cell lung carcinoma.